Skip to main content
Top

Open Access 09-06-2025 | Type 2 Diabetes | Commentary

Self-care and self-management in diabetes: concepts, theories and practices

Authors: Saranya Puzhakkal, Sallianne Kavanagh, Barbara Conway, Chia Siang Kow, Syed Shahzad Hasan

Published in: International Journal of Clinical Pharmacy

Login to get access

Abstract

Diabetes mellitus is a progressive disorder that requires the active participation of individuals with diabetes to improve management and delay the onset of acute and chronic complications. Effective diabetes care necessitates a multifaceted approach involving insulin therapy, non-insulin anti-diabetic drugs and lifestyle adjustments. Self-management and self-care are integral, yet distinct, components of diabetes care. While both play a pivotal role in optimising diabetes care, their distinctions and similarities are often misunderstood. These terms are frequently used interchangeably. Although some activities are unique to each concept, inconsistencies exist in the published literature. Self-management refers to patient behaviours guided by healthcare professionals, whereas self-care encompasses autonomous actions patients take to maintain health and prevent complications. Both concepts involve activities that foster long-term collaboration between patients and healthcare professionals.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Self-care and self-management in diabetes: concepts, theories and practices
Authors
Saranya Puzhakkal
Sallianne Kavanagh
Barbara Conway
Chia Siang Kow
Syed Shahzad Hasan
Publication date
09-06-2025
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-025-01941-z

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more